| Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems JC Kraft, JP Freeling, Z Wang, RJY Ho Journal of pharmaceutical sciences 103 (1), 29-52, 2014 | 713 | 2014 |
| Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 AC Walls, B Fiala, A Schäfer, S Wrenn, MN Pham, M Murphy, ... Cell 183 (5), 1367-1382. e17, 2020 | 482 | 2020 |
| Adjuvanting a subunit COVID-19 vaccine to induce protective immunity PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... Nature 594 (7862), 253-258, 2021 | 298 | 2021 |
| Interactions of Indocyanine Green and Lipid in Enhancing Near-Infrared Fluorescence Properties: The Basis for Near-Infrared Imaging in Vivo JC Kraft, RJY Ho Biochemistry 53 (8), 1275-1283, 2014 | 175 | 2014 |
| An experimental paradigm for the prediction of Post-Operative Pain (PPOP) R Landau, JC Kraft, LY Flint, B Carvalho, P Richebé, M Cardoso, ... JoVE (Journal of Visualized Experiments), e1671, 2010 | 149 | 2010 |
| Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention EA Krogstad, R Ramanathan, C Nhan, JC Kraft, AK Blakney, S Cao, ... Biomaterials 144, 1-16, 2017 | 64 | 2017 |
| Mechanism-based pharmacokinetic (MBPK) models describe the complex plasma kinetics of three antiretrovirals delivered by a long-acting anti-HIV drug combination nanoparticle … JC Kraft, LA McConnachie, J Koehn, L Kinman, J Sun, AC Collier, ... Journal of Controlled Release 275, 229-241, 2018 | 55 | 2018 |
| Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma JC Kraft, LA McConnachie, J Koehn, L Kinman, C Collins, DD Shen, ... Aids 31 (6), 765-770, 2017 | 52 | 2017 |
| Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy Y Gao, JC Kraft, D Yu, RJY Ho European Journal of Pharmaceutics and Biopharmaceutics 138, 75-91, 2019 | 49 | 2019 |
| Three HIV drugs, atazanavir, ritonavir, and tenofovir, coformulated in drug-combination nanoparticles exhibit long-acting and lymphocyte-targeting properties in nonhuman primates S Perazzolo, LM Shireman, J Koehn, LA McConnachie, JC Kraft, ... Journal of pharmaceutical sciences 107 (12), 3153-3162, 2018 | 46 | 2018 |
| Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS J Shao, JC Kraft, B Li, J Yu, J Freeling, J Koehn, RJ Ho Nanomedicine 11 (5), 545-564, 2016 | 43 | 2016 |
| Pharmacogenetics and anaesthesia: the value of genetic profiling R Landau, LA Bollag, JC Kraft Anaesthesia 67 (2), 165-179, 2012 | 43 | 2012 |
| Long-acting profile of 4 drugs in 1 anti-HIV nanosuspension in nonhuman primates for 5 weeks after a single subcutaneous injection LA McConnachie, LM Kinman, J Koehn, JC Kraft, S Lane, W Lee, ... Journal of pharmaceutical sciences 107 (7), 1787-1790, 2018 | 42 | 2018 |
| In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid JC Kraft, GL Osterhaus, AN Ortiz, PA Garris, MA Johnson Neuroscience 161 (3), 940-949, 2009 | 39 | 2009 |
| Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens BJ Read, L Won, JC Kraft, I Sappington, A Aung, S Wu, J Bals, C Chen, ... Cell reports 38 (2), 2022 | 38 | 2022 |
| Indocyanine green nanoparticles undergo selective lymphatic uptake, distribution and retention and enable detailed mapping of lymph vessels, nodes and abnormalities JC Kraft, PM Treuting, RJY Ho Journal of drug targeting 26 (5-6), 494-504, 2018 | 38 | 2018 |
| Pharmacogenetics in obstetric anesthesia R Landau, JC Kraft Current Opinion in Anesthesiology 23 (3), 323-329, 2010 | 38 | 2010 |
| Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses B McLeod, MT Mabrouk, K Miura, R Ravichandran, S Kephart, ... Immunity 55 (9), 1680-1692. e8, 2022 | 36 | 2022 |
| Stabilization of the SARS-CoV-2 spike receptor-binding domain using deep mutational scanning and structure-based design D Ellis, N Brunette, KHD Crawford, AC Walls, MN Pham, C Chen, ... Frontiers in immunology 12, 710263, 2021 | 36 | 2021 |
| Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook Q Mu, J Yu, LA McConnachie, JC Kraft, Y Gao, GK Gulati, RJY Ho Journal of drug targeting 26 (5-6), 435-447, 2018 | 35 | 2018 |
